EAM
Erste Asset Management’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70.7M | Buy |
1,011,961
+51,313
| +5% | +$3.59M | 0.59% | 36 |
|
|
2025
Q1 | $70.7M | Hold |
960,648
| – | – | 0.91% | 25 |
|
|
2024
Q4 | $63.2M | Buy |
960,648
+30,000
| +3% | +$1.97M | 0.77% | 31 |
|
|
2024
Q3 | $72.4M | Sell |
930,648
-20,000
| -2% | -$1.56M | 0.87% | 26 |
|
|
2024
Q2 | $74.2M | Sell |
950,648
-30,000
| -3% | -$2.34M | 0.98% | 21 |
|
|
2024
Q1 | $66.6M | Buy |
980,648
+121,000
| +14% | +$8.22M | 0.91% | 24 |
|
|
2023
Q4 | $57.9M | Sell |
859,648
-60,000
| -7% | -$4.04M | 0.85% | 27 |
|
|
2023
Q3 | $62.2M | Buy |
919,648
+156,000
| +20% | +$10.6M | 1.07% | 14 |
|
|
2023
Q2 | $54.5M | Buy |
763,648
+600,000
| +367% | +$42.8M | 0.96% | 17 |
|
|
2023
Q1 | $11.3M | Hold |
163,648
| – | – | 0.22% | 121 |
|
|
2022
Q4 | $11.1M | Buy |
163,648
+12,200
| +8% | +$831K | 0.24% | 117 |
|
|
2022
Q3 | $8.32M | Hold |
151,448
| – | – | 0.19% | 143 |
|
|
2022
Q2 | $10.2M | Buy |
151,448
+16,000
| +12% | +$1.07M | 0.23% | 120 |
|
|
2022
Q1 | $9.09M | Buy |
135,448
+20,600
| +18% | +$1.38M | 0.17% | 150 |
|
|
2021
Q4 | $6.74M | Sell |
114,848
-51,500
| -31% | -$3.02M | 0.12% | 178 |
|
|
2021
Q3 | $9.93M | Buy |
166,348
+36,348
| +28% | +$2.17M | 0.2% | 134 |
|
|
2021
Q2 | $7.82M | Hold |
130,000
| – | – | 0.16% | 153 |
|
|
2021
Q1 | $6.5M | Hold |
130,000
| – | – | 0.16% | 158 |
|
|
2020
Q4 | $6.49M | Buy |
+130,000
| New | +$6.49M | 0.18% | 145 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 472 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 453 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 438 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 443 |
|